Xu Xiangshan, Wang Lijie, Wang Guofeng, Jin Yuanzhe
Department of Cardiology, 4th Affiliated Hospital of China Medical University, Shenyang, China.
J Biomater Appl. 2017 Jan;31(6):911-922. doi: 10.1177/0885328216675829. Epub 2016 Nov 10.
The coronary artery stent has been widely used in clinic. In-stent restenosis was mainly caused by the excessive proliferation of smooth muscle cell and the inflammation due to the metal ion released from stent scaffold of the drug-eluting stent. Thus, to reduce the in-stent restenosis and promote the vascular endothelialization have become a hot research point in this area. In this paper, a nano-TiO ceramic coating was deposited on 316L stainless steel to reduce the metal ion release and to inhibit the inflammation reaction. An endothelia cell selective adhesion peptide Arg-Glu-Asp-Val (REDV) coating was prepared on the ceramic coating by a polydopamine technology to promote the endothelialization. The corrosion test indicated that nano-TiO ceramic film could effectively decrease the nickel ion released from 316L stainless steel. REDV/TiO coating could promote the endothelial cell adhesion and proliferation, meanwhile REDV/TiO coating could also increase the nitric oxide concentration. Bare metal stent, TiO-coated stent and REDV/TiO-coated stent were implanted in the iliac arteries of rabbit model. In-stent restenosis and re-endothelialization were evaluated at 28 days post-implantation of the stents. The results showed that REDV/TiO-coated stents could effectively reduce in-stent restenosis and promote re-endothelialization in comparison with TiO-coated drug-eluting stent and bare metal stent. These results suggest that REDV/TiO-coated drug-eluting stent maybe a good choice of the application for coronary artery disease.
冠状动脉支架已在临床上广泛应用。支架内再狭窄主要是由平滑肌细胞过度增殖以及药物洗脱支架的支架支架释放的金属离子引起的炎症所致。因此,减少支架内再狭窄并促进血管内皮化已成为该领域的研究热点。本文在316L不锈钢上沉积了纳米TiO陶瓷涂层,以减少金属离子释放并抑制炎症反应。通过聚多巴胺技术在陶瓷涂层上制备了内皮细胞选择性粘附肽Arg-Glu-Asp-Val(REDV)涂层,以促进内皮化。腐蚀试验表明,纳米TiO陶瓷膜可有效降低316L不锈钢释放的镍离子。REDV/TiO涂层可促进内皮细胞粘附和增殖,同时REDV/TiO涂层还可提高一氧化氮浓度。将裸金属支架、TiO涂层支架和REDV/TiO涂层支架植入兔模型的髂动脉中。在支架植入后28天评估支架内再狭窄和再内皮化情况。结果表明,与TiO涂层药物洗脱支架和裸金属支架相比,REDV/TiO涂层支架可有效减少支架内再狭窄并促进再内皮化。这些结果表明,REDV/TiO涂层药物洗脱支架可能是冠状动脉疾病应用的一个良好选择。